SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

09 Feb 2022 Evaluate
The sales slipped to Rs. 384.60 millions for the December 2021 quarter as against Rs. 495.50 millions during the year-ago period.Profit after Tax for the quarter ended December 2021 saw a decline of -73.01% from Rs. 54.10 millions to Rs. 14.60  millions.The company reported a degrowth in operating Profit to 42.10 millions from 82.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 384.60 495.50 -22.38 1597.00 1630.40 -2.05 2036.70 2263.30 -10.01
Other Income 13.70 25.90 -47.10 56.50 71.40 -20.87 86.70 114.80 -24.48
PBIDT 42.10 82.50 -48.97 293.10 291.70 0.48 338.10 416.90 -18.90
Interest 2.10 1.70 23.53 6.50 3.70 75.68 7.60 8.60 -11.63
PBDT 40.00 80.80 -50.50 286.60 288.00 -0.49 330.50 408.30 -19.05
Depreciation 16.40 16.40 0.00 51.00 43.40 17.51 60.30 58.80 2.55
PBT 23.60 64.40 -63.35 235.60 244.60 -3.68 270.20 349.50 -22.69
TAX 9.00 10.30 -12.62 63.20 62.20 1.61 68.10 86.50 -21.27
Deferred Tax 0.80 -4.50 -117.78 -1.80 -1.50 20.00 -2.80 -11.70 -76.07
PAT 14.60 54.10 -73.01 172.40 182.40 -5.48 202.10 263.00 -23.16
Equity 57.30 57.30 0.00 57.30 57.30 0.00 57.30 57.30 0.00
PBIDTM(%) 10.95 16.65 -34.26 18.35 17.89 2.58 16.60 18.42 -9.88

Bharat Parenterals Share Price

1185.70 -27.40 (-2.26%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×